{"id":"recombinant-human-neuregulin-for-injection","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reaction"},{"rate":"5-10%","effect":"Flu-like symptoms"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to and activating the ErbB4 receptor on cardiac cells, stimulating the expression of genes involved in cardiac development and function. This leads to improved cardiac function and reduced fibrosis.","oneSentence":"Recombinant human Neuregulin for injection is a growth factor that promotes cardiac repair and regeneration.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:31:43.462Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute myocardial infarction"},{"name":"Heart failure"}]},"trialDetails":[{"nctId":"NCT04468529","phase":"PHASE3","title":"Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure","status":"COMPLETED","sponsor":"Zensun Sci. & Tech. Co., Ltd.","startDate":"2020-12-10","conditions":"Chronic Systolic Heart Failure","enrollment":154},{"nctId":"NCT03388593","phase":"PHASE3","title":"Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.","status":"UNKNOWN","sponsor":"Zensun Sci. & Tech. Co., Ltd.","startDate":"2018-07-23","conditions":"Chronic Heart Failure","enrollment":1600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Neucardin"],"phase":"phase_3","status":"active","brandName":"Recombinant human Neuregulin for injection","genericName":"Recombinant human Neuregulin for injection","companyName":"Zensun Sci. & Tech. Co., Ltd.","companyId":"zensun-sci-tech-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Recombinant human Neuregulin for injection is a growth factor that promotes cardiac repair and regeneration. Used for Acute myocardial infarction, Heart failure.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}